Myalgic Encephalomyelitis Group Australia Ltd

Myalgic Encephalomyelitis Group Australia Ltd ME Group Australia is a registered Australian charity whose purpose is to advance health for ME. Promoting knowledge and awareness of ME.
3.

Myalgic Encephalomyelitis Group Australia Ltd (ME Group Australia) is a registered Australian charity whose purpose is to advance health for people with Myalgic Encephalomyelitis (pwME) by undertaking any of the following activities:

1. Creating and or facilitating a network for ME patients and communities.
2. Promoting the official diagnosis of ME for Disability Support Pension, NDIS Access Requ

est, and research participation.
4. Providing support for research into the causes, diagnosis, treatment and/or management of the disease.
5. Providing information for patients and medical professionals regarding the most recent developments in best practice for diagnosing, treating and/or managing ME.
6. Establishing and operating clinics for the diagnosis, management and treatment of ME, for research collaboration and the provision of support for sufferers.
7. Lobbying and facilitating the Application for the Recognition of Medical Specialty of ME under the Health Practitioner Regulation National Law.
* These activities may be undertaken on an Australia wide basis

We envisage the first ME Clinic as a small GP surgery style in Logan City, QLD which will provide โ€œofficial ME diagnosisโ€ and symptom management strategy until effective pharmaceutical treatment is introduced through research and trials. Until such time as better diagnostic criteria can be published, the company will adopt Myalgic Encephalomyelitis: International Consensus Criteria (ME (ICC)) for planning and operation of the company. The clinic will adopt International Consensus Primer for Medical Practitioners (ICP) as a guideline for diagnosis and management. Logan City is conveniently located between Brisbane and Gold Coast where participants of The National Centre for Neuroimmunology and Emerging Diseases (NCNED) is concentrated.

๐Ÿค“๐Ÿ™๐Ÿ’™
09/06/2026

๐Ÿค“๐Ÿ™๐Ÿ’™

๐—ก๐—ผ๐˜ƒ๐—ฒ๐—น ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜†: ๐—œ๐—บ๐—ฝ๐—ฎ๐—ถ๐—ฟ๐—ฒ๐—ฑ ๐—ง๐—ฅ๐—ฃ๐— ๐Ÿฏ ๐—ฎ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ถ๐˜๐˜† ๐—ฑ๐—ถ๐˜€๐—ฟ๐˜‚๐—ฝ๐˜๐˜€ ๐—บ๐—ถ๐˜๐—ผ๐—ฐ๐—ต๐—ผ๐—ป๐—ฑ๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฐ๐—ฎ๐—น๐—ฐ๐—ถ๐˜‚๐—บ ๐—ฑ๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ถ๐—ป ๐— ๐—˜/๐—–๐—™๐—ฆ

Over many years, our team at the NCNED has produced rigorous scientific evidence demonstrating that problems with ion channels, particularly TRPM3, TRPM7 and TRPM2, disrupts calcium entry into the cells, providing important and evidence-based insights into the pathomechanism of ME/CFS.

Our latest research has pushed the envelope to take this work a major step forward. Five years ago, this idea was conceived. We then had the painstaking task of developing, testing and refining the technology to test our idea.

For the first time, we have been able to witness calcium movement inside components of living immune cells as outlined in the diagram below in real time using advanced imaging techniques.

๐—ช๐—ต๐—ฎ๐˜ ๐˜„๐—ฒ ๐—ผ๐—ฏ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ฑ ๐˜„๐—ฎ๐˜€ ๐—ฎ ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—ป๐˜€๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜ ๐˜„๐—ผ๐—ฟ๐—น๐—ฑ ๐—ณ๐—ถ๐—ฟ๐˜€๐˜ ๐—ณ๐—ถ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐—ถ๐—ป๐—ด ๐˜€๐—ถ๐—ด๐—ป๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ป๐˜ ๐—ง๐—ฅ๐—ฃ๐— ๐Ÿฏ -๐—ฐ๐—ฎ๐—น๐—ฐ๐—ถ๐˜‚๐—บ ๐—ฑ๐—ฒ๐—ฝ๐—ฒ๐—ป๐—ฑ๐—ฒ๐—ป๐˜ ๐—ฝ๐—ฎ๐˜๐—ต๐˜„๐—ฎ๐˜† ๐—ฑ๐˜†๐˜€๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฒ๐—ป๐˜๐—ฟ๐˜† ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—บ๐—ถ๐˜๐—ผ๐—ฐ๐—ต๐—ผ๐—ป๐—ฑ๐—ฟ๐—ถ๐—ฎ ๐—ผ๐—ณ ๐—ฝ๐—ฒ๐—ผ๐—ฝ๐—น๐—ฒ ๐—น๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐˜„๐—ถ๐˜๐—ต ๐— ๐—˜/๐—–๐—™๐—ฆ.

๐—ช๐—ต๐—ฒ๐—ป ๐—ง๐—ฅ๐—ฃ๐— ๐Ÿฏ ๐—ถ๐˜€ ๐—ป๐—ผ๐˜ ๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐—ถ๐—ป๐—ด ๐—ฝ๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฟ๐—น๐˜†, ๐˜€๐—ถ๐—ด๐—ป๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ป๐˜ ๐—ฐ๐—ฎ๐—น๐—ฐ๐—ถ๐˜‚๐—บ ๐—ฑ๐˜†๐˜€๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ฐ๐—ฐ๐˜‚๐—ฟ๐˜€ ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—บ๐—ถ๐˜๐—ผ๐—ฐ๐—ต๐—ผ๐—ป๐—ฑ๐—ฟ๐—ถ๐—ฎ, ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ฒ๐—น๐—น ๐—ฒ๐˜€๐˜€๐—ฒ๐—ป๐˜๐—ถ๐—ฎ๐—น ๐—ณ๐—ผ๐—ฟ ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ด๐˜† ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ฒ๐˜๐—ฎ๐—ฏ๐—ผ๐—น๐—ถ๐—ฐ ๐—ฝ๐—ฟ๐—ผ๐—ฐ๐—ฒ๐˜€๐˜€๐—ฒ๐˜€.

๐—Ÿ๐—ถ๐—ป๐—ธ: https://link.springer.com/article/10.1186/s12865-026-00849-1

This latest study provides for mechanistic explanation linking impaired TRPM3 function and reduced calcium entry into the mitochondria with the consequences on the low-energy state and symptoms experienced by people with ME/CFS.

This research at the NCNED is an example of our ongoing commitment to push the boundaries of technology and its application into pathomechanisms and drug investigations in ME/CFS.

NCNED is excited that other international researchers are now investigating ion channels and their role with calcium in ME/CFS as ion channels are not only present on the cell surface, but also ion channels are located inside the cell on other structures of the cell.

As the national peak research centre for ME/CFS, we have been working for some time on new innovative technologies for furthering our discoveries as well as new research findings that will be released later this year on TRPM8 activity and large-scale transcriptomic investigations.

The NCNED team would like every person with ME/CFS to know you are our first priority; we are driven and determined to make a difference for you.

Best wishes,
Sonya and the NCNED Team

NCNED would like to express our gratitude and appreciation to all the volunteers, Support Groups and the following Organizations:
โ€ข The Stafford Fox Medical Research Foundation
โ€ข National Health and Medical Research Council
โ€ข MERUK
โ€ข Dr John Hamwood
โ€ข The McCusker Charitable Foundation
โ€ข Mr Adrian Flack
โ€ข Talei Stewart
โ€ข The Alison Hunter Memorial Foundation
โ€ข The Buxton Foundation
โ€ข The Henty Community
โ€ข The Blake Beckett Foundation
โ€ข Change for ME Charity
โ€ข QLD ME/CFS/FM Support Association
โ€ข WA ME/CFS and Lyme Association
โ€ข Fibromyalgia ME/CFS Gold Coast Support Group Inc
โ€ข Tweed ME/CFS/FM Lyme Support Group
โ€ข ME/CFS South Australia Inc
โ€ข ME/CFS & FM Association NSW Inc
โ€ข ME/CFS Australia Ltd

Griffith University, Griffith Health, , , , , , , , , , , , , , , , , , , Tom Kindlon's ME CFS & related page: News, Research and more, ME/CFS Australia, ME Australia, ME CFS and Lyme Association of WA, ME/CFS/FM Support Association QLD Inc, Fibromyalgia me/cfs Gold Coast Support Group Inc., Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, My QoL, ME/ CFS South Australia Inc, Myalgic Encephalomyelitis Group Australia Ltd, ME Research UK, Me/cfs San Diego, Myalgic Encephalomyelitis M.E Chronic Fatigue Syndrome CFS Science, Leeds ME Network, Stichting ME Research, Bristol ME Support Group, Oxfordshire ME Group for Action, ME Long Covid unite SA, May 12th International ME CFS FM Awareness Day Australia, FJD/Robotech Robot line markers Australia

03/06/2026

NCNED Researcher Mr Tanoj Singh presented the latest diffusion MRI research findings in ME/CFS and long COVID at the Young EMERG Symposium 2026, held on 25 - 26 May at Wellcome Genome Campus, Cambridge, UK.

Mr Singh showcased preliminary evidence of brain tissue microstructural alterations and demonstrated how advanced diffusion MRI modelling techniques can improve understanding of neurobiology underlying ME/CFS and long COVID.

His presentation emphasised the importance of incorporating advance neuroimaging methods to enhance the knowledge of neurological features associated with these conditions.

Best wishes,
Sonya and the NCNED team

NCNED would like to express our gratitude and appreciation to all the volunteers, Support Groups and the following Organizations:
โ€ข The Stafford Fox Medical Research Foundation
โ€ข National Health and Medical Research Council
โ€ข MERUK
โ€ข Dr John Hamwood
โ€ข The McCusker Charitable Foundation
โ€ข Mr Adrian Flack
โ€ข Talei Stewart
โ€ข The Alison Hunter Memorial Foundation
โ€ข The Buxton Foundation
โ€ข The Henty Community
โ€ข The Blake Beckett Foundation
โ€ข Change for ME Charity
โ€ข QLD ME/CFS/FM Support Association
โ€ข WA ME/CFS and Lyme Association
โ€ข Fibromyalgia ME/CFS Gold Coast Support Group Inc
โ€ข Tweed ME/CFS/FM Lyme Support Group
โ€ข ME/CFS South Australia Inc
โ€ข ME/CFS & FM Association NSW Inc
โ€ข ME/CFS Australia Ltd
โ€ข National Advocacy Advisory Council for ME/CFS

Griffith University, Griffith Health, , , , , , , , , , , , , , , , , , , Tom Kindlon's ME CFS & related page: News, Research and more, ME/CFS Australia, ME Australia, ME CFS and Lyme Association of WA, ME/CFS/FM Support Association QLD Inc, Fibromyalgia me/cfs Gold Coast Support Group Inc., Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, My QoL, ME/ CFS South Australia Inc, Myalgic Encephalomyelitis Group Australia Ltd, Australian National Advisory Advocacy Council for ME/CFS Research - NAAC, ME Research UK, Me/cfs San Diego, Myalgic Encephalomyelitis M.E Chronic Fatigue Syndrome CFS Science, Leeds ME Network, Stichting ME Research, Bristol ME Support Group, Oxfordshire ME Group for Action, ME Long Covid unite SA, May 12th International ME CFS FM Awareness Day Australia, FJD/Robotech Robot line markers Australia

Happy June!Here is our June Newsletter. We hope you find this edition interesting. WarmlyTeam MEGA ๐Ÿ’™                    ...
03/06/2026

Happy June!

Here is our June Newsletter. We hope you find this edition interesting.

Warmly
Team MEGA ๐Ÿ’™



Happy June! Here is our latest Newsletter. We hope you find this edition interesting. Team MEGA

๐Ÿ’™
29/05/2026

๐Ÿ’™

NCNED Researcher Mr Tuong Huynh presented the most recent research outputs at the Young EMERG Symposium 2026, held on 25 - 26 May at Wellcome Genome Campus, Cambridge, UK.

Mr Huynh presented his preliminary findings to classify ME/CFS from healthy controls using machine learning algorithms. He identified the best machine learning algorithm and key MRI features that distinguish people living with ME/CFS from healthy controls.

This presentation reflected NCNEDโ€™s ongoing commitment to improving understanding of neurological features associated with ME/CFS and fostering innovative machine learning strategies in the field.

Best wishes,
Sonya and the NCNED team

NCNED would like to express our gratitude and appreciation to all the volunteers, Support Groups and the following Organizations:
โ€ข The Stafford Fox Medical Research Foundation
โ€ข National Health and Medical Research Council
โ€ข MERUK
โ€ข Dr John Hamwood
โ€ข The McCusker Charitable Foundation
โ€ข Mr Adrian Flack
โ€ข Talei Stewart
โ€ข The Alison Hunter Memorial Foundation
โ€ข The Buxton Foundation
โ€ข The Henty Community
โ€ข The Blake Beckett Foundation
โ€ข Change for ME Charity
โ€ข QLD ME/CFS/FM Support Association
โ€ข WA ME/CFS and Lyme Association
โ€ข Fibromyalgia ME/CFS Gold Coast Support Group Inc
โ€ข Tweed ME/CFS/FM Lyme Support Group
โ€ข ME/CFS South Australia Inc
โ€ข ME/CFS & FM Association NSW Inc
โ€ข ME/CFS Australia Ltd
โ€ข National Advocacy Advisory Council for ME/CFS

Griffith University, Griffith Health, , , , , , , , , , , , , , , , , , , Tom Kindlon's ME CFS & related page: News, Research and more, ME/CFS Australia, ME Australia, ME CFS and Lyme Association of WA, ME/CFS/FM Support Association QLD Inc, Fibromyalgia me/cfs Gold Coast Support Group Inc., Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, My QoL, ME/ CFS South Australia Inc, Myalgic Encephalomyelitis Group Australia Ltd, Australian National Advisory Advocacy Council for ME/CFS Research - NAAC, Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, ME Research UK, Me/cfs San Diego, Myalgic Encephalomyelitis M.E Chronic Fatigue Syndrome CFS Science, Leeds ME Network, Stichting ME Research, Bristol ME Support Group, Oxfordshire ME Group for Action, ME Long Covid unite SA, May 12th International ME CFS FM Awareness Day Australia, FJD/Robotech Robot line markers Australia

FYI ๐ŸŒปIn order to advocate for Assistive Technology (AT) for complex and not well understood disability like Myalgic Ence...
26/05/2026

FYI ๐ŸŒป

In order to advocate for Assistive Technology (AT) for complex and not well understood disability like Myalgic Encephalomyelitis (ME), supporting evidence backed with journal publications could be a powerful skillset for successful AT request.

Clare can make the journey a little fun with uplifting and eye opening discussion with your peer Occupational Therapist.



Note:
Just realised this session was this morning. ๐Ÿ˜…
Follow Your OT Tutor to find out what was discussed during the session.

They usually share the recordings for members as on demand CPD.

JOURNAL CLUB โ€“ Overcoming barriers to assistive technology use

Occupational therapists play an important role in prescribing assistive technology (AT), but do you know how to effectively support clients through concerns about stigma, the views of others, and the psychological acceptance of needing AT?

Are your AT prescriptions supporting long-term self-management, or just focusing on short-term goals?

Knowing how to prescribe AT is one thing, but what systems do you currently have in place to ensure routine follow-up after a device is delivered, and what strategies do you use to keep your own AT knowledge current?

In the next Your OT Tutor Journal Club session, weโ€™ll be reviewing the barriers to using assistive technology for individuals with chronic conditions. Weโ€™ll hear about what the research evidence is telling us, then chat about how we can apply it in our everyday practice. It will be applicable to those working in both community and hospital settings.

The sessions are running on Tuesday 26th May at 9.30am and 1.00pm (AEST). They will be recorded but youโ€™ll get much more out of it if you come live and join the discussion.

To come along youโ€™ll need to be a YOTT Journal Club member. For only $47 you get 12-months access to the on-demand library (with 20+ other recorded sessions) and youโ€™ll be invited to 5 live sessions over the 12-month period.

Or if youโ€™re looking for even more CPD options, become a YOTT Alliance or YOTT Connector member and youโ€™ll be able to access the journal club as a free bonus!

Find out more here: https://yott.au/journalclub

Potentially the pathology that could explain all ME impairments and symptoms. ๐ŸŽ–๏ธ๐ŸŒป๐Ÿ’™
26/05/2026

Potentially the pathology that could explain all ME impairments and symptoms. ๐ŸŽ–๏ธ๐ŸŒป๐Ÿ’™

๐—–๐—ผ๐—ป๐—ด๐—ฟ๐—ฎ๐˜๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€!!

Chandi Magawa and the NCNED team are thrilled to announce the submission of a novel and innovative PhD thesis that pushed the boundaries of ion channel research in ME/CFS and long COVID.

Chandiโ€™s PhD research was the first to identify distinct TRPM3 isoforms in NK cells from both healthy controls and people with ME/CFS. Our previous research has documented genetic and functional changes in TRPM3; however, TRPM3 doesnโ€™t appear as just one version of itself, and these different versions are called isoforms. Each isoform may work differently which may be clinically relevant to disease pathology. Chandiโ€™s research is significant to not only understand the pathomechanisms of illness, but also to contribute to NCNEDโ€™s research on biomarker development for diagnosis and treatment.

This thesis also documents novel insights into TRPM3 ion channel function that has never before been investigated. We know from previous research that TRPM3 ion channel function is reduced, leading to decreased calcium entry into cells of people with ME/CFS and long COVID. An innovative research project using live cell immunofluorescent imaging enabled comprehensive research into whether TRPM3 dysfunction resulted in impaired calcium entry into components known as organelles within the cells. Previous research has suggested that ME/CFS is a potential mitochondrial disease; however, this research project demonstrates that mitochondrial disturbances are instead linked with changes in calcium through TRPM3.

Sonya and the NCNED team congratulate Chandi Magawa on this incredible achievement and for the significant contribution to advancing our understanding of ME/CFS and long COVID.

Best wishes,
Sonya and the NCNED team

NCNED would like to express our gratitude and appreciation to all the volunteers, Support Groups and the following Organizations:
โ€ข The Stafford Fox Medical Research Foundation
โ€ข National Health and Medical Research Council
โ€ข MERUK
โ€ข Dr John Hamwood
โ€ข The McCusker Charitable Foundation
โ€ข Mr Adrian Flack
โ€ข Talei Stewart
โ€ข The Alison Hunter Memorial Foundation
โ€ข The Buxton Foundation
โ€ข The Henty Community
โ€ข The Blake Beckett Foundation
โ€ข Change for ME Charity
โ€ข QLD ME/CFS/FM Support Association
โ€ข WA ME/CFS and Lyme Association
โ€ข Fibromyalgia ME/CFS Gold Coast Support Group Inc
โ€ข Tweed ME/CFS/FM Lyme Support Group
โ€ข ME/CFS South Australia Inc
โ€ข ME/CFS & FM Association NSW Inc
โ€ข ME/CFS Australia Ltd
โ€ข National Advocacy Advisory Council for ME/CFS

Griffith University, Griffith Health, , , , , , , , , , , , , , , , , , , Tom Kindlon's ME CFS & related page: News, Research and more, ME/CFS Australia, ME Australia, ME CFS and Lyme Association of WA, ME/CFS/FM Support Association QLD Inc, Fibromyalgia me/cfs Gold Coast Support Group Inc., Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, My QoL, ME/ CFS South Australia Inc, Myalgic Encephalomyelitis Group Australia Ltd, Australian National Advisory Advocacy Council for ME/CFS Research - NAAC, ME Research UK, Me/cfs San Diego, Myalgic Encephalomyelitis M.E Chronic Fatigue Syndrome CFS Science, Leeds ME Network, Stichting ME Research, Bristol ME Support Group, Oxfordshire ME Group for Action, ME Long Covid unite, May 12th International ME CFS FM Awareness Day Australia, FJD/Robotech Robot line markers Australia

๐ŸŽ–๏ธ๐Ÿ™๐ŸŒป๐Ÿ’™
26/05/2026

๐ŸŽ–๏ธ๐Ÿ™๐ŸŒป๐Ÿ’™

๐—–๐—ผ๐—ป๐—ด๐—ฟ๐—ฎ๐˜๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€!!

Chandi Magawa and the NCNED team are thrilled to announce the submission of a novel and innovative PhD thesis that pushed the boundaries of ion channel research in ME/CFS and long COVID.

Chandiโ€™s PhD research was the first to identify distinct TRPM3 isoforms in NK cells from both healthy controls and people with ME/CFS. Our previous research has documented genetic and functional changes in TRPM3; however, TRPM3 doesnโ€™t appear as just one version of itself, and these different versions are called isoforms. Each isoform may work differently which may be clinically relevant to disease pathology. Chandiโ€™s research is significant to not only understand the pathomechanisms of illness, but also to contribute to NCNEDโ€™s research on biomarker development for diagnosis and treatment.

This thesis also documents novel insights into TRPM3 ion channel function that has never before been investigated. We know from previous research that TRPM3 ion channel function is reduced, leading to decreased calcium entry into cells of people with ME/CFS and long COVID. An innovative research project using live cell immunofluorescent imaging enabled comprehensive research into whether TRPM3 dysfunction resulted in impaired calcium entry into components known as organelles within the cells. Previous research has suggested that ME/CFS is a potential mitochondrial disease; however, this research project demonstrates that mitochondrial disturbances are instead linked with changes in calcium through TRPM3.

Sonya and the NCNED team congratulate Chandi Magawa on this incredible achievement and for the significant contribution to advancing our understanding of ME/CFS and long COVID.

Best wishes,
Sonya and the NCNED team

NCNED would like to express our gratitude and appreciation to all the volunteers, Support Groups and the following Organizations:
โ€ข The Stafford Fox Medical Research Foundation
โ€ข National Health and Medical Research Council
โ€ข MERUK
โ€ข Dr John Hamwood
โ€ข The McCusker Charitable Foundation
โ€ข Mr Adrian Flack
โ€ข Talei Stewart
โ€ข The Alison Hunter Memorial Foundation
โ€ข The Buxton Foundation
โ€ข The Henty Community
โ€ข The Blake Beckett Foundation
โ€ข Change for ME Charity
โ€ข QLD ME/CFS/FM Support Association
โ€ข WA ME/CFS and Lyme Association
โ€ข Fibromyalgia ME/CFS Gold Coast Support Group Inc
โ€ข Tweed ME/CFS/FM Lyme Support Group
โ€ข ME/CFS South Australia Inc
โ€ข ME/CFS & FM Association NSW Inc
โ€ข ME/CFS Australia Ltd
โ€ข National Advocacy Advisory Council for ME/CFS

Griffith University, Griffith Health, , , , , , , , , , , , , , , , , , , Tom Kindlon's ME CFS & related page: News, Research and more, ME/CFS Australia, ME Australia, ME CFS and Lyme Association of WA, ME/CFS/FM Support Association QLD Inc, Fibromyalgia me/cfs Gold Coast Support Group Inc., Chronic Fatigue Syndrome & Fibromyalgia NSW, Australia, My QoL, ME/ CFS South Australia Inc, Myalgic Encephalomyelitis Group Australia Ltd, Australian National Advisory Advocacy Council for ME/CFS Research - NAAC, ME Research UK, Me/cfs San Diego, Myalgic Encephalomyelitis M.E Chronic Fatigue Syndrome CFS Science, Leeds ME Network, Stichting ME Research, Bristol ME Support Group, Oxfordshire ME Group for Action, ME Long Covid unite, May 12th International ME CFS FM Awareness Day Australia, FJD/Robotech Robot line markers Australia

17/05/2026

Many of you have raised concerns with me and my team about the major changes to the NDIS recently proposed by the Albanese government. With the legislation introduced just last week - and likely to be pushed through Parliament next week - Iโ€™m worried there wonโ€™t be enough time for proper scrutiny or amendments.

So, this week Iโ€™ll be hosting two community consultation sessions; one online and one in person, so you can share your views. Whether youโ€™re a participant, family member, or provider, your voice matters and you deserve to be heard.

If you can't make it to these sessions, I'd really value your feedback by email. I'll also be putting aside time for phone calls with constituents during the week.

Online session: 18 May, 5:15pm - 6:15pm
In person session: 19 May, 5:15pm - 6:15pm Meeting Room 1, Camberwell Library, 340 Camberwell Road
RSVP: https://www.moniqueryan.com.au/events
Email: [email protected]

๐Ÿ™๐Ÿ’™
17/05/2026

๐Ÿ™๐Ÿ’™

We know it can be life changing whn   (OT) listens what are barriers and challenges for   to live everyday life and be p...
16/05/2026

We know it can be life changing whn (OT) listens what are barriers and challenges for to live everyday life and be part of community.

When (AT) truly โ€œassistโ€, it would give us sense of achievement and hope for the future.

Butโ€ฆ, itโ€™s easy to fall for a not-so-helpful AT.
That could potentially cause more barriers and challenges to pwME.

We hear a lot about pwME denied their requests for wheelchair.
It is a great AT to conserve energy for pwME and prevents further deterioration.

Also pwME are shy about using wheelchair.

In our humble opinion:
* OT could advocate for importance of wheelchair for pwME based on evidence and lived experiences.
* OT could encourage and educate pwME how to use it and when to use it.
* OT could evaluate the value and improved quality of life since the introduction of AT. Or identify further barriers and challenges when itโ€™s not fulfilling the purpose for the prescription. (And if it was an unsuccessful outcome, we think peers and community would like to know about it to prevent them falling into the same mistake.)

As a laypeople, we are curious to know what kind of literature and evidence they will be discussing. ๐Ÿค“๐Ÿ’™๐ŸŒป

JOURNAL CLUB โ€“ Overcoming barriers to assistive technology use

Occupational therapists play an important role in prescribing assistive technology (AT), but do you know how to effectively support clients through concerns about stigma, the views of others, and the psychological acceptance of needing AT?

Are your AT prescriptions supporting long-term self-management, or just focusing on short-term goals?

Knowing how to prescribe AT is one thing, but what systems do you currently have in place to ensure routine follow-up after a device is delivered, and what strategies do you use to keep your own AT knowledge current?

In the next Your OT Tutor Journal Club session, weโ€™ll be reviewing the barriers to using assistive technology for individuals with chronic conditions. Weโ€™ll hear about what the research evidence is telling us, then chat about how we can apply it in our everyday practice. It will be applicable to those working in both community and hospital settings.

The sessions are running on Tuesday 26th May at 9.30am and 1.00pm (AEST). They will be recorded but youโ€™ll get much more out of it if you come live and join the discussion.

To come along youโ€™ll need to be a YOTT Journal Club member. For only $47 you get 12-months access to the on-demand library (with 20+ other recorded sessions) and youโ€™ll be invited to 5 live sessions over the 12-month period.

Or if youโ€™re looking for even more CPD options, become a YOTT Alliance or YOTT Connector member and youโ€™ll be able to access the journal club as a free bonus!

Find out more here: https://yott.au/journalclub

Address

Suite 2. 03 120 Chalk Street
Tanah Merah, QLD
4030

Alerts

Be the first to know and let us send you an email when Myalgic Encephalomyelitis Group Australia Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share